Possibilities for treatment - do not delay

This article was commissioned by Regenecell Pty Ltd, to supplement the current anecdotal data on stem cell therapy. For additional information, contact: info@regenecell.com

The disease types, mostly degenerative, that Regenecell can treat with stem cell therapy are finite and we now know how most of them will respond, and to what degree regeneration will occur. This is based on factors such as age, duration of illness, degree of debility etc. and our understanding of this is important to successful treatments and the continued survival of stem cell companies.

The factor that is most important to the public, however, is not any of the above, but relates rather to the decision to undergo therapy. We know that certain degenerative diseases respond poorly, but have no other method of treatment in Western medicine. The reason that these diseases respond poorly has nothing to do with the supposed inability of stem cell therapy to treat the condition, but simply, that the patient arrived too late.

Stem cell therapy is seen as a last resort, the final, most expensive and miraculous treatment that has been hailed by the media as a cure-all for everything from cancer to acne and the disastrous effect of this is that patients tend to wait until they have exhausted all other avenues. Unfortunately most of these avenues are in the arena of animal cell injections, bee-sting therapy, ozone therapy, chelation therapy or goat serum infusions, which all have been proven useless in the degenerative disease types that we can treat.

If one has to take ALS (Lou Gehrig's disease) as an example, you would notice that responses to stem cell therapy only lie in the 40-50% range and for Multiple Sclerosis (MS) the responses are in the 70-80% range. This response rate relates to two factors:

» The speed of progression of the disease and, since ALS is a fast degenerative disorder, the speed of stem cell regeneration struggles to keep up with it. MS is slower and therefore responses are better and hold better for longer periods of time.

» The late presentation of the patient. By the time ALS patients finally decide to come for therapy they have advanced disease, of which some components, like muscle wasting and nerve degeneration leading to swallowing and breathing problems, do not respond to stem cell therapy. We can then only hope for prolonging of life with therapy.

Two human behaviours account for this delay: hope and false hope. Patients hope that medical science will finally find a cure and believe, falsely, that bogus treatments will cure their disease. Not even stem cell therapy will cure it, and if a cure was found, would we not know about it?

We urge patients to make informed decisions earlier and not become victim to practitioners who make false promises. Stem cell therapy is not cheap - our product alone accounts for more than 50% of the cost, but it has benefit in the right disease at the right time, and that time is not in the terminal phase. Do not delay your decision - it may have even more costly consequences.